SCHEMBL21413784

SCHEMBL21413784

CC(=O)CNC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARA Q07869 9/20 0.62
▸ PPARG P37231 3/20 0.62
▸ FABP2 P12104 2/20 0.62
▸ SLC22A12 Q96S37 1/20 0.62
▸ MAPT P10636 3/20 0.56
▸ SMN1; SMN2 Q16637 3/20 0.56
▸ ALDH1A1 P00352 3/20 0.56
▸ USP2 O75604 2/20 0.56
▸ POLB P06746 2/20 0.56
▸ HTT P42858 1/20 0.56
▸ CYP1A2 P05177 4/20 0.55
▸ CYP3A4 P08684 4/20 0.55
▸ CNR1 P21554 4/20 0.55
▸ CYP2C19 P33261 3/20 0.55
▸ TDP1 Q9NUW8 2/20 0.55
▸ MEN1 O00255 2/20 0.55
▸ KMT2A Q03164 2/20 0.55
▸ CYP2C9 P11712 2/20 0.55
▸ ABCB11 O95342 2/20 0.55
▸ TSHR P16473 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4755781 0.90 PPARA (0.66) PPARAPPARGFABP2SLC22A12MAPT
SCHEMBL22221502 0.86 PPARA (0.58) PPARAPPARGFABP2SLC22A12MAPT
SCHEMBL15682174 0.85 PPARA (0.56) PPARAPPARGFABP2SLC22A12MAPT
SCHEMBL22221670 0.84 PPARA (0.62) PPARAPPARGFABP2SLC22A12MAPT
SCHEMBL21413781 0.84 PPARA (0.74) PPARAPPARGFABP2MAPTSMN1; SMN2
SCHEMBL15682182 0.83 ELANE (0.55) PPARAPPARGFABP2SLC22A12MAPT
SCHEMBL1584395 0.83 PPARA (0.60) PPARAPPARGFABP2SLC22A12MAPT
SCHEMBL11160679 0.82 PPARA (0.56) PPARAPPARGFABP2SLC22A12MAPT
SCHEMBL22221663 0.82 PPARA (0.59) PPARAPPARGFABP2SLC22A12MAPT
SCHEMBL22221473 0.82 PPARA (0.64) PPARAPPARGFABP2SLC22A12MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10428013-B2 Amide compound, preparation method and uses thereof SHANGHAI INSTITUTE OF PHAMACEUTICAL INDUSTRY (CN) 2019-10-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10428013-B2 Amide compound, preparation method and uses thereof F12, NR1H3, F2 PPARA 185/4885PPARG 171/4885FABP2 176/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback